This compound is primarily utilized in the field of medicinal chemistry as a key intermediate or building block in the synthesis of biologically active molecules. Its unique structure, featuring a trifluoromethyl group and a spirocyclic system, makes it valuable for developing pharmaceutical agents, particularly those targeting central nervous system disorders. The trifluoromethyl group enhances the compound's metabolic stability and lipophilicity, which can improve drug absorption and bioavailability. Additionally, the spirocyclic framework contributes to the three-dimensional complexity of the molecule, making it a useful scaffold for designing compounds with high selectivity and potency. Researchers often explore its potential in creating novel therapeutics for conditions such as depression, anxiety, and neurodegenerative diseases.